Seizure count an inaccurate endpoint in epilepsy trials

 

Several recent studies have reported that patient-reported seizure count, a common endpoint used in clinical trials of antiepileptic agents, is highly inaccurate, with patients failing to report a majority of the seizures that occur.

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page